Groundbreaking laser therapy offers alternative to surgery for breast cancer CHICAGO, Sept. 28, 2021 /PRNewswire/ — Novian Health Inc. has been granted Breakthrough Device designation from the U.S. Food and Drug Administration for its Novilase®Interstitial Laser System and its proposed indication for use: the focal destruction of malignant breast tumors in adult women who seek […]
Novian Health Inc. Announces the Second Close of Convertible Note Financing (23 August 2021)
CHICAGO, Aug. 23, 2021 /PRNewswire/ — Novian Health Inc. (Novian), a clinical stage medical device company focused on the development of image-guided laser therapy for the focal destruction of malignant and benign breast tumors, announced today the second closing of a private placement financing, with total cash proceeds to date of about $7.5 million. The […]
Novian Health Inc. Announces the First Close of Convertible Note Financing (28 July 2021)
Contact: Liz Dowling, (415) 388-2794 Dowling & Dennis PR Liz@dowlingdennis.net CHICAGO, July 28, 2021 /PRNewswire/ — Novian Health Inc. (Novian), a clinical stage medical device company focused on the development of image-guided laser therapy for the focal destruction of malignant and benign breast tumors, announced today the first closing of a private placement financing, raising […]
Novian Health to Present at the Cavendish Global Summit on February 25, 2021 (12 February 2021)
February 12, 2021 Contact: Eugene Bajorinas, (312) 266-7200 E-mail: info@novianhealth.com Series B Financing will enable European commercialization and U.S. market approval of Laser Therapy System CHICAGO – Novian Health, developer of Novilase® Breast Therapy, announced today that it has been selected to present at the Cavendish Global Summit on February 25th. This exclusive virtual opportunity […]